Blood-based biomarkers in AD : When the Future Becomes the Present

Time: 9:00 am
day: Day One


  • Understanding the current blood-based biomarker landscape: p-tau and neurofilament light chain (NfL)
  • Overcoming the gaps and solutions for biomarker discovery and replication
  • Discussing key considerations of use for blood-based biomarkers in clinical settings and drug development